BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22616181)

  • 21. Bioequivalence study of two azithromycin formulations in healthy subjects.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Sari AP; Rimainar A
    Arzneimittelforschung; 2009; 59(9):471-5. PubMed ID: 19856795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and bioequivalence study of two gemfibrozil preparations.
    Benkö S; Drabant S; Grézal G; Urmös I; Csörgö M; Klebovich I
    Arzneimittelforschung; 1997 Aug; 47(8):913-6. PubMed ID: 9296277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine bioavailability of two physically different oral formulations.
    Postolache P; Petrescu O; Dorneanu V; Zanini AC
    Eur Rev Med Pharmacol Sci; 2002; 6(6):127-31. PubMed ID: 12776806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence study of two minocycline capsule formulations in healthy volunteers.
    Setiawati E; Purnomo A; Deniati SH; Yunaidi DA; Handayani LR; Harinato G; Santoso ID
    Arzneimittelforschung; 2009; 59(10):532-6. PubMed ID: 19998582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence study of montelukast tablets in healthy Pakistani volunteers.
    Abbas M; Khan AM; Amin S; Riffat S; Ashraf M; Waheed N
    Pak J Pharm Sci; 2013 Mar; 26(2):255-9. PubMed ID: 23455193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose bioequivalence study of alpha-methyldopa tablet formulations using a modified HPLC method.
    Valizadeh H; Nemati M; Hallaj-Nezhadi S; Ansarin M; Zakeri-Milani P
    Arzneimittelforschung; 2010; 60(10):607-11. PubMed ID: 21125810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and bioequivalence evaluation of two brands of ciprofloxacin 500 mg tablets in Iranian healthy volunteers.
    Valizadeh H; Hamishehkar H; Ghanbarzadeh S; Zabihian N; Zakeri-Milani P
    Arzneimittelforschung; 2012 Dec; 62(12):566-70. PubMed ID: 23047470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability investigation of two different oral formulations of citalopram, a so-called 'second generation' antidepressant drug.
    Gschwend MH; Richter J; Sennewald R; Guserle R; Renner J; Martin W
    Arzneimittelforschung; 2005; 55(12):730-7. PubMed ID: 16430026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
    Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
    Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter.
    Vlase L; Bodiu B; Leucuta SE
    Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral.
    Kees F; Mair G; Dittmar M; Bucher M
    Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioequivalence study of atorvastatin tablets.
    Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):573-7. PubMed ID: 15497662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metronidazole immediate release formulations: a fasting randomized open-label crossover bioequivalence study in healthy volunteers.
    de Freitas Silva M; Schramm SG; Kano EK; Koono EE; Manfio JL; Porta V; dos Reis Serra CH
    Arzneimittelforschung; 2012 Oct; 62(10):490-5. PubMed ID: 22918856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability investigation of two different oral formulations of methylprednisolone.
    Geister U; Guserle R; Bungers E; Schaarschmidt D; Doser K
    Arzneimittelforschung; 2000 Mar; 50(3):286-92. PubMed ID: 10758783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.
    Hussein RF; Lockyer M; Hammami MM
    Arzneimittelforschung; 2007; 57(2):101-5. PubMed ID: 17396620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence studies of tacrolimus capsule under fasting and fed conditions in healthy male and female subjects.
    Lainesse A; Hussain S; Monif T; Reyar S; Tippabhotla SK; Madan A; Thudi NR
    Arzneimittelforschung; 2008; 58(5):242-7. PubMed ID: 18589558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative bioavailability study of two cefixime formulations administered orally in healthy male volunteers.
    Zakeri-Milani P; Valizadeh H; Islambulchilar Z
    Arzneimittelforschung; 2008; 58(2):97-100. PubMed ID: 18412024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers.
    Li J; Tian Y; Zhang ZJ; Wang N; Ren X; Chen Y
    Arzneimittelforschung; 2009; 59(5):228-32. PubMed ID: 19537522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets.
    Wong H; Ozalp Y; Lainesse A; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):618-24. PubMed ID: 15497670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence study of rofecoxib tablets.
    Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):624-8. PubMed ID: 15497671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.